Qingdao Brightmoon Advanced Marine Biomaterial Technology Co., Ltd.  is a subsidiary of Qingdao Brightmoon Seaweed Group Co., Ltd., established in May 2018, located at No. 688 Yongjun Road, Huangdao District, Qingdao City.

We specialize in the application of alginates in tissue engineering and regenerative medicine. We are the only producer of ultrapure sodium alginate in China, offering the BriMAL series  with a monthly maximum supply of up to 20 kg.

The company has a GMP workshop that can meet the requirements of pharmaceutical production. Ultrapure sodium alginate completed the CDE registration for medicinal excipients (No.: F20210000344) in 2021, and the main document registration for medical devices (No.: M2023149) in 2023. Bacterial endotoxins are as low as 20EU/g, which is better than industry standards (YY/T 1654-2019) and international similar products, and the specifications can be customized.

The ultrapure sodium alginate produced by the company meets the requirements of in vivo implantation standards, and can be prepared into solutions, gel, microspheres, cell loaded microcapsules and other implant and interventional medical devices, providing new solutions for cell loading, embolization, filling and slow release for preclinical research of acute liver failure, tumor, diabetes, Parkinson's disease, heart failure, intractable pain, urinary incontinence and other diseases. 

The company's main products include ultrapure sodium alginate powder and its products (solutions, gel, microspheres, cell loaded microcapsules, etc.), ultrapure calcium alginate, oxidized sodium alginate, functional group grafted modified sodium alginate, and reagent grade sodium alginate (molecular weight, G content customized). We can provide precision filtration and sterilization services for high viscosity solutions such as sodium alginate.